80 Participants Needed

Reducing Vaccine Hesitancy for COVID-19

AK
SW
Overseen BySunny W Kim, Ph.D
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Arizona State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

COVID-19 vaccines are available to children over six months, and these vaccines are powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have lower COVID-19 vaccination rates than White non-Hispanic children .Our team of health communication and public health experts proposes a community-based theory-driven intervention that utilizes culturally-grounded narratives from digital storytelling to reduce Hispanic parents' COVID-19 vaccine hesitancy and increase their children's vaccine uptake.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Digital Storytelling Intervention for reducing vaccine hesitancy for COVID-19?

Research shows that digital storytelling can change people's knowledge, attitudes, and behaviors in public health, including vaccination. Digital messages from health professionals have also been shown to promote preventive behaviors and vaccination, suggesting that storytelling could be an effective way to reduce vaccine hesitancy.12345

Is the Digital Storytelling Intervention safe for humans?

The research articles provided do not contain specific safety data for the Digital Storytelling Intervention or its other names. However, storytelling has been used in health care settings among vulnerable populations without reported safety concerns.678910

How does this treatment for reducing COVID-19 vaccine hesitancy differ from others?

This treatment is unique because it focuses on addressing vaccine hesitancy through educational and narrative-based interventions, rather than using financial incentives or focusing solely on intentions. It aims to improve understanding and acceptance of vaccines by tackling misinformation and enhancing communication strategies.311121314

Research Team

AK

Alexis Koskan, Ph.D

Principal Investigator

Arizona State University

SW

Sunny W Kim, Ph.D

Principal Investigator

Arizona State University

Eligibility Criteria

This trial is for Hispanic parents or guardians of children under 18 who haven't had their COVID-19 vaccinations up to date. Participants must self-identify as Hispanic, be willing to communicate via text, and provide a photo of their child's immunization record.

Inclusion Criteria

You identify as Hispanic.
I am a parent or legal guardian of a child under 18.
You consent to sending and receiving a text message, as well as submitting a photograph of your child's vaccination history for T3 data gathering.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Baseline Assessment

Participants complete a baseline assessment using the web-based data collection platform before random assignment to control or intervention arm

1 week
1 visit (virtual)

Intervention

Participants in the intervention group watch digital stories about COVID-19 vaccine experiences among Hispanic parents

4 weeks
1 visit (virtual)

Follow-up

Participants are monitored for changes in vaccine hesitancy and vaccination behaviors

2 months
1 visit (virtual)

Treatment Details

Interventions

  • Digital Storytelling Intervention
  • Information Control Intervention
Trial Overview The study tests if digital storytelling can reduce vaccine hesitancy among Hispanic parents. It involves comparing the effects of receiving culturally-tailored stories about vaccines with just getting basic information.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Baseline and Digital Storytelling (DST)Experimental Treatment2 Interventions
Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to DST arm. The intervention group participants will watch the four selected digital stories about COVID-19 vaccine experiences among Hispanic parents of children. Each story was made with voice, images, and sound (3-5 minutes each). Intervention group participants will complete the Time 2 (T2) online survey immediately after the DST intervention. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).
Group II: Baseline and ControlActive Control2 Interventions
Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to control arm. Control group participants will receive a CDC COVID-19 Vaccine Information Sheet appropriate for their child's age before completing the T2 assessment. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Arizona State University

Lead Sponsor

Trials
311
Recruited
109,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Findings from Research

A systematic review of seven randomized controlled trials found that digital messages from health professionals, particularly physician videos on platforms like Facebook, can significantly reduce COVID-19 infections.
The review also indicated that these digital interventions effectively promote preventive behaviors, such as vaccination and information-seeking, although many studies had concerns regarding bias.
Effect of digital messages from health professionals on COVID-19-related outcomes: A systematic review of randomized controlled trials.Kuwahara, K., Sakamoto, M., Ishizuka, R., et al.[2023]
Storytelling (ST) has been identified as an effective tool for changing public knowledge, attitudes, and behaviors regarding health issues, with 7 out of 10 analyzed studies using ST for this purpose.
Despite the positive impact of ST in public health interventions, the studies reviewed showed limited follow-up and evaluation, indicating a need for more comprehensive assessments to fully understand its effectiveness.
Storytelling as a Research Tool Used to Explore Insights and as an Intervention in Public Health: A Systematic Narrative Review.McCall, B., Shallcross, L., Wilson, M., et al.[2022]
A study involving 31 participants from the Pfizer/BioNTech COVID-19 vaccine trial revealed that motivations for vaccination included a desire to end the pandemic, protect others, and support scientific progress, highlighting the importance of these themes in promoting vaccine uptake.
Participants expressed concerns about side effects and the rapid development of the vaccine, but they addressed these concerns by normalizing side effects and emphasizing the safety of the expedited process, suggesting that effective communication can alleviate vaccine hesitancy.
The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.Wentzell, E., Racila, AM.[2022]

References

Effect of digital messages from health professionals on COVID-19-related outcomes: A systematic review of randomized controlled trials. [2023]
Storytelling as a Research Tool Used to Explore Insights and as an Intervention in Public Health: A Systematic Narrative Review. [2022]
The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion. [2022]
Development of a Digital Storytelling Intervention to Increase Breast, Cervical, and Colorectal Cancer Screening in the Hispanic/Latino Community: a Qualitative Evaluation. [2023]
Enhancing Physician's Toolkit: Integrating Storytelling in Medical Practice. [2021]
Animated, video entertainment-education to improve vaccine confidence globally during the COVID-19 pandemic: an online randomized controlled experiment with 24,000 participants. [2022]
Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review. [2022]
Storytelling: A Qualitative Tool to Promote Health Among Vulnerable Populations. [2022]
User preferences for a mobile application to report adverse events following vaccination. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Health Communication and Decision Making about Vaccine Clinical Trials during a Pandemic. [2022]
A Web-Based Public Health Intervention for Addressing Vaccine Misinformation: Protocol for Analyzing Learner Engagement and Impacts on the Hesitancy to Vaccinate. [2022]
Intervention studies to encourage vaccination using narrative: a systematic scoping review protocol. [2022]
Impact of an Education Intervention on COVID-19 Vaccine Hesitancy in a Military Base Population. [2022]
Interventions for COVID-19 Vaccine Hesitancy: A Systematic Review and Narrative Synthesis. [2023]